1. Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen

   • Peter L. Pedersen

   Introduction 19 September 2007 Pages: 211 - 222

2. Hypoxia, glucose metabolism and the Warburg’s effect

   • Ramon Bartrons
   • Jaime Caro

   Mini Review 28 July 2007 Pages: 223 - 229

3. HIF-1 mediates the Warburg effect in clear cell renal carcinoma

   • Gregg L. Semenza

   Mini Review 06 June 2007 Pages: 231 - 234

4. Actuality of Warburg’s views in our understanding of renal cancer metabolism

   • Catherine Godinot
   • Elodie de Laplanche
   • Hélène Simonnet

   Mini Review 31 July 2007 Pages: 235 - 241

5. A pivotal role for p53: balancing aerobic respiration and glycolysis

   • Wenzhe Ma
   • Ho Joong Sung
   • Paul M. Hwang

   Mini Review 06 June 2007 Pages: 243 - 246

6. Oxygen metabolism and a potential role for cytochrome c oxidase in the Warburg effect

   • Paul C. Herrmann
   • E. Clifford Herrmann

   Mini Review 21 June 2007 Pages: 247 - 250

7. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?

   • Robert J. Gillies
   • Robert A. Gatenby

   Mini Review 12 July 2007 Pages: 251 - 257

8. A message emerging from development: the repression of mitochondrial β-F1-ATPase expression in cancer

   • José M. Cuezva
   • María Sánchez-Aragó
   • Álvaro D. Ortega

   Mini Review 22 August 2007 Pages: 259 - 265

9. The Warburg effect and its cancer therapeutic implications

   • Zhao Chen
   • Weiqin Lu
   • Peng Huang

   MIni Review 06 June 2007 Pages: 267 - 274